Basic Information

Drug ID DDPD11581 ...
Drug Name Venetoclax
Molecular Weight 868.45
Molecular Formula C45H50ClN7O7S
CAS Number 1257044-40-8
SMILES CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1
External Links
DRUGBANK DB11581
PubChem Compound 49846579
PDR 3916
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
Log P 99.0 - 99.0 - MSDS

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Reference
AUC 32800.0 ng.h/ml 32.8±16.9 ug.h/ml PO, oral; low fat meal; DRUGBANK
C Max 2100.0 ng/ml 2.1±1.1 ug/ml PO, oral; low fat meal; DRUGBANK
T Max 6.5 h 5-8 h PO, oral; food; DRUGBANK
Volume of Distribution 288.5 L 256-321 L Apparent volume of distribution; DRUGBANK
Half-life 22.5 h 19-26 h Single dose; DRUGBANK
Toxicity LD50 2001.0 mg/kg >2001 mg/kg PO, oral; mouse; DRUGBANK
Eliminate Route 99.9 % >99.9 % Faeces excretion; Oral single dose; normal,healthy; human, homo sapiens; DRUGBANK
Eliminate Route 0.0100 % <0.01 % Urinary excretion; Oral single dose; normal,healthy; human, homo sapiens; DRUGBANK
Eliminate Route 20.8 % 20.8 % Faeces excretion; Oral single dose; normal,healthy; human, homo sapiens; Unchanged drug; DRUGBANK

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for adults 400.0 mg/day 400 mg/day PO, oral Venclexta venetoclax PDR
Max dose for adults 400.0 mg/day 400 mg/day PO, oral Venclexta venetoclax PDR
Max dose for adults 600.0 mg/day 600 mg/day PO, oral Venclexta venetoclax PDR
Max dose for geriatric 400.0 mg/day 400 mg/day PO, oral Venclexta venetoclax PDR
Max dose for geriatric 400.0 mg/day 400 mg/day PO, oral Venclexta venetoclax PDR
Max dose for geriatric 600.0 mg/day 600 mg/day PO, oral Venclexta venetoclax PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1